Allstate Corporation’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.61M | Buy |
70,092
+26,491
| +61% | +$2.18M | 0.06% | 209 |
|
|
2025
Q4 | $3.72M | Buy |
43,601
+22,511
| +107% | +$1.85M | 0.05% | 238 |
|
|
2025
Q3 | $1.64M | Buy |
+21,090
| New | +$1.65M | 0.04% | 265 |
|
|
2025
Q2 | – | Sell |
-16,747
| Closed | -$1.21M | – | 305 |
|
|
2025
Q1 | $1.21M | Sell |
16,747
-1,028
| -6% | -$73.6K | 0.04% | 294 |
|
|
2024
Q4 | $1.32M | Buy |
+17,775
| New | +$1.24M | 0.04% | 254 |
|
|
2023
Q3 | – | Sell |
-2,618
| Closed | -$247K | – | 210 |
|
|
2023
Q2 | $247K | Hold |
2,618
| – | – | 0.02% | 184 |
|
|
2023
Q1 | $217K | Sell |
2,618
-17,681
| -87% | -$1.39M | 0.02% | 191 |
|
|
2022
Q4 | $1.51M | Sell |
20,299
-7,300
| -26% | -$563K | 0.05% | 257 |
|
|
2022
Q3 | $2.28M | Buy |
27,599
+281
| +1% | +$27K | 0.07% | 171 |
|
|
2022
Q2 | $2.6M | Buy |
27,318
+6,469
| +31% | +$670K | 0.08% | 155 |
|
|
2022
Q1 | $2.45M | Sell |
20,849
-26,914
| -56% | -$3.02M | 0.07% | 217 |
|
|
2021
Q4 | $6.19M | Buy |
47,763
+27,311
| +134% | +$3.19M | 0.12% | 135 |
|
|
2021
Q3 | $2.31M | Sell |
20,452
-917
| -4% | -$105K | 0.1% | 104 |
|
|
2021
Q2 | $2.21M | Sell |
21,369
-814
| -4% | -$76.7K | 0.07% | 121 |
|
|
2021
Q1 | $1.85M | Buy |
22,183
+537
| +2% | +$45.4K | 0.06% | 171 |
|
|
2020
Q4 | $1.98M | Sell |
21,646
-2,638
| -11% | -$219K | 0.06% | 132 |
|
|
2020
Q3 | $1.94M | Sell |
24,284
-1,013
| -4% | -$79K | 0.06% | 106 |
|
|
2020
Q2 | $1.75M | Sell |
25,297
-2,987
| -11% | -$212K | 0.06% | 139 |
|
|
2020
Q1 | $1.78M | Sell |
28,284
-34,935
| -55% | -$2.52M | 0.07% | 130 |
|
|
2019
Q4 | $4.92M | Buy |
63,219
+150
| +0.2% | +$11.7K | 0.09% | 142 |
|
|
2019
Q3 | $4.62M | Hold |
63,069
| – | – | 0.08% | 148 |
|
|
2019
Q2 | $3.88M | Buy |
63,069
+7,332
| +13% | +$443K | 0.07% | 162 |
|
|
2019
Q1 | $3.56M | Buy |
55,737
+27
| +0% | +$1.54K | 0.1% | 155 |
|
|
2018
Q4 | $2.84M | Buy |
+55,710
| New | +$2.82M | 0.09% | 168 |
|
|
2016
Q3 | – | Sell |
-121,158
| Closed | -$4.03M | – | 179 |
|
|
2016
Q2 | $4.03M | Hold |
121,158
| – | – | 0.26% | 94 |
|
|
2016
Q1 | $3.56M | Sell |
121,158
-1,143
| -0.9% | -$31.5K | 0.31% | 98 |
|
|
2015
Q4 | $3.22M | Buy |
122,301
+19,101
| +19% | +$496K | 0.31% | 92 |
|
|
2015
Q3 | $2.44M | Hold |
103,200
| – | – | 0.25% | 117 |
|
|
2015
Q2 | $2.45M | Buy |
+103,200
| New | +$2.33M | 0.22% | 101 |
|
|
2014
Q1 | – | Sell |
-641,532
| Closed | -$7.03M | – | 218 |
|
|
2013
Q4 | $7.03M | Buy |
+641,532
| New | +$7.23M | 0.26% | 98 |
|
Other funds holding EW
VCM
VPM
Allstate Corporation's EW Position: Q1 2026 in Review
Allstate Corporation increased its Edwards Lifesciences (EW) stake by 61% in Q1 2026, buying an estimated $2.18M and bringing the position to 70,092 shares worth $5.61M. The position accounts for 0.06% of the portfolio, ranked #209.
Allstate Corporation first reported a position in EW in Q4 2013 and has held it in 30 quarters since. The position peaked at $7.03M in Q4 2013. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Allstate Corporation held 70,092 shares of Edwards Lifesciences worth $5.61M as of Q1 2026.
- Allstate Corporation bought 26,491 Edwards Lifesciences shares in Q1 2026, an estimated $2.18M.
- Edwards Lifesciences made up 0.06% of Allstate Corporation's portfolio in Q1 2026, its #209 holding.
- Allstate Corporation first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 30 quarters since.
- Allstate Corporation's Edwards Lifesciences position peaked at $7.03M in Q4 2013.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.